M.D.C. Holdings, Inc. (NYSE:MDC) Shares Bought by MetLife Investment Advisors LLC

MetLife Investment Advisors LLC grew its holdings in shares of M.D.C. Holdings, Inc. (NYSE:MDC) by 8.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 20,801 shares of the construction company’s stock after purchasing an additional 1,540 shares during the period. MetLife Investment Advisors LLC’s holdings in M.D.C. were worth $604,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Comerica Bank grew its position in M.D.C. by 0.7% in the 4th quarter. Comerica Bank now owns 49,645 shares of the construction company’s stock valued at $1,522,000 after buying an additional 338 shares in the last quarter. Piedmont Investment Advisors Inc. grew its position in M.D.C. by 3.6% in the 4th quarter. Piedmont Investment Advisors Inc. now owns 10,780 shares of the construction company’s stock valued at $303,000 after buying an additional 378 shares in the last quarter. Legal & General Group Plc boosted its position in shares of M.D.C. by 0.4% during the 4th quarter. Legal & General Group Plc now owns 108,282 shares of the construction company’s stock valued at $3,047,000 after purchasing an additional 454 shares in the last quarter. Magnus Financial Group LLC boosted its position in shares of M.D.C. by 8.0% during the 1st quarter. Magnus Financial Group LLC now owns 7,996 shares of the construction company’s stock valued at $232,000 after purchasing an additional 592 shares in the last quarter. Finally, Bank of Montreal Can boosted its position in shares of M.D.C. by 14.1% during the 4th quarter. Bank of Montreal Can now owns 4,908 shares of the construction company’s stock valued at $138,000 after purchasing an additional 605 shares in the last quarter. 74.76% of the stock is currently owned by institutional investors.

Shares of NYSE MDC traded up $0.04 during midday trading on Thursday, reaching $37.56. 390,640 shares of the company traded hands, compared to its average volume of 412,474. The firm has a market capitalization of $2.31 billion, a price-to-earnings ratio of 10.23, a PEG ratio of 1.34 and a beta of 1.15. The business’s 50-day moving average price is $33.67. M.D.C. Holdings, Inc. has a 12 month low of $25.14 and a 12 month high of $37.75. The company has a current ratio of 8.58, a quick ratio of 2.19 and a debt-to-equity ratio of 0.68.

M.D.C. (NYSE:MDC) last released its quarterly earnings results on Tuesday, April 30th. The construction company reported $0.64 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.59 by $0.05. M.D.C. had a return on equity of 14.20% and a net margin of 6.90%. The business had revenue of $647.28 million during the quarter, compared to analysts’ expectations of $597.26 million. During the same period in the previous year, the business posted $0.63 earnings per share. The firm’s revenue for the quarter was up 6.5% compared to the same quarter last year. Equities analysts expect that M.D.C. Holdings, Inc. will post 3.33 earnings per share for the current fiscal year.

In related news, Chairman Larry A. Mizel sold 20,224 shares of M.D.C. stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $33.48, for a total value of $677,099.52. Following the completion of the sale, the chairman now directly owns 146,182 shares in the company, valued at $4,894,173.36. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Robert Nathaniel Martin sold 7,000 shares of M.D.C. stock in a transaction dated Friday, May 31st. The stock was sold at an average price of $31.79, for a total value of $222,530.00. The disclosure for this sale can be found here. Insiders sold 234,962 shares of company stock valued at $7,671,544 over the last ninety days. 26.30% of the stock is currently owned by company insiders.

A number of research firms have recently issued reports on MDC. Wedbush began coverage on shares of Uber Technologies in a research report on Wednesday, May 1st. They issued an “outperform” rating and a $65.00 price target for the company. ValuEngine lowered shares of Intersect ENT from a “buy” rating to a “hold” rating in a research report on Monday, July 8th. Zacks Investment Research lowered shares of ExlService from a “hold” rating to a “sell” rating in a research report on Wednesday, July 10th. Finally, JPMorgan Chase & Co. upgraded M.D.C. from an “underweight” rating to a “neutral” rating in a report on Monday, July 8th. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. M.D.C. has an average rating of “Buy” and a consensus target price of $33.80.

About M.D.C.

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.

See Also: How Do Investors Open a Backdoor Roth IRA?

Institutional Ownership by Quarter for M.D.C. (NYSE:MDC)

Receive News & Ratings for M.D.C. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M.D.C. and related companies with MarketBeat.com's FREE daily email newsletter.